X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (131419) 131419
Newsletter (5103) 5103
Newspaper Article (2563) 2563
Book Chapter (701) 701
Magazine Article (189) 189
Dissertation (85) 85
Book / eBook (78) 78
Trade Publication Article (63) 63
Transcript (56) 56
Government Document (37) 37
Publication (35) 35
Conference Proceeding (18) 18
Web Resource (8) 8
Book Review (7) 7
Reference (5) 5
Report (2) 2
Streaming Video (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (77134) 77134
animals (50488) 50488
vascular endothelial growth factor (42678) 42678
male (40087) 40087
female (37837) 37837
angiogenesis (29080) 29080
mice (21696) 21696
expression (21040) 21040
middle aged (20077) 20077
research (18881) 18881
analysis (17860) 17860
adult (16690) 16690
oncology (16111) 16111
aged (16084) 16084
cancer (15977) 15977
cell biology (15052) 15052
proteins (14498) 14498
rats (14449) 14449
cells, cultured (14301) 14301
endothelial growth-factor (14252) 14252
inflammation (14066) 14066
gene expression (13070) 13070
cardiac & cardiovascular systems (12915) 12915
risk factors (12826) 12826
endothelium (12623) 12623
peripheral vascular disease (12324) 12324
apoptosis (11473) 11473
health aspects (11379) 11379
atherosclerosis (11341) 11341
care and treatment (11303) 11303
vascular endothelial growth factor a - metabolism (11152) 11152
medicine (11040) 11040
research article (10492) 10492
cardiovascular disease (10451) 10451
physiological aspects (10353) 10353
physiology (10102) 10102
rodents (9995) 9995
cells (9908) 9908
vegf (9853) 9853
hypertension (9539) 9539
immunohistochemistry (9322) 9322
studies (9175) 9175
signal transduction (9166) 9166
multidisciplinary sciences (9084) 9084
diabetes (9049) 9049
medicine & public health (9003) 9003
medicine, research & experimental (8758) 8758
biochemistry & molecular biology (8727) 8727
cardiovascular diseases (8719) 8719
oxidative stress (8611) 8611
endothelial cells (8529) 8529
activation (8252) 8252
tumors (8219) 8219
kinases (8174) 8174
disease models, animal (7989) 7989
metastasis (7902) 7902
surgery (7873) 7873
neovascularization (7697) 7697
science (7250) 7250
cytokines (7179) 7179
stem cells (7094) 7094
disease (6973) 6973
cell proliferation (6922) 6922
hypoxia (6850) 6850
hematology (6842) 6842
genetic aspects (6763) 6763
cardiology (6718) 6718
ophthalmology (6651) 6651
prognosis (6649) 6649
pharmacology & pharmacy (6512) 6512
biology (6428) 6428
in-vitro (6379) 6379
time factors (6298) 6298
cardiovascular system (6292) 6292
vascular endothelial growth factor a - genetics (6267) 6267
cardiovascular (6260) 6260
medical research (6255) 6255
development and progression (6253) 6253
growth (6182) 6182
mice, inbred c57bl (6170) 6170
growth factors (6115) 6115
treatment outcome (5976) 5976
in-vivo (5950) 5950
aged, 80 and over (5937) 5937
endothelium, vascular - metabolism (5916) 5916
mortality (5765) 5765
endocrinology & metabolism (5747) 5747
heart (5744) 5744
endothelial-cells (5700) 5700
patients (5672) 5672
rats, sprague-dawley (5659) 5659
cell line, tumor (5646) 5646
inhibition (5640) 5640
phosphorylation (5598) 5598
ischemia (5514) 5514
endothelium, vascular - cytology (5453) 5453
review (5429) 5429
proliferation (5388) 5388
therapy (5376) 5376
pregnancy (5316) 5316
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (139613) 139613
Chinese (623) 623
Japanese (352) 352
German (202) 202
Russian (74) 74
French (68) 68
Spanish (64) 64
Polish (57) 57
Portuguese (55) 55
Korean (31) 31
Turkish (21) 21
Italian (10) 10
Czech (6) 6
Hungarian (6) 6
Persian (6) 6
Latvian (2) 2
Romanian (2) 2
Slovenian (2) 2
Arabic (1) 1
Belarusian (1) 1
Bulgarian (1) 1
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
Indonesian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2010, Volume 107, Issue 6, pp. 2425 - 2430
Vascular endothelial growth factors (VEGFs) regulate blood and lymph vessel formation through activation of three receptor tyrosine kinases, VEGFR-1, -2, and -3... 
Proteins | Angiogenesis | Receptors | Vascular endothelial growth factors | Endothelial growth factors | Ligands | Dimers | Chimeras | Monomers | Crystal structure | Vascular endothelial growth factor receptor-2 | Lymphangiogenesis | Vascular endothelial growth factor C | ACTIVATION | COMPLEX | FACTOR-C | angiogenesis | CRYSTAL-STRUCTURE | MULTIDISCIPLINARY SCIENCES | ORF-VIRUS | TYROSINE KINASES | vascular endothelial growth factor receptor-2 | VASCULAR-PERMEABILITY | FAMILY-MEMBER | lymphangiogenesis | KINASE DOMAIN RECEPTOR | vascular endothelial growth factor C | Humans | Crystallography, X-Ray | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - genetics | Recombinant Fusion Proteins - metabolism | Spodoptera | Vascular Endothelial Growth Factor Receptor-2 - genetics | Vascular Endothelial Growth Factor A - chemistry | Vascular Endothelial Growth Factor C - chemistry | Vascular Endothelial Growth Factor Receptor-1 - genetics | Protein Structure, Tertiary | Cell Line | Cell Survival | Models, Molecular | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Binding Sites - genetics | Recombinant Fusion Proteins - chemistry | Vascular Endothelial Growth Factor Receptor-3 - metabolism | Vascular Endothelial Growth Factor Receptor-1 - chemistry | Vascular Endothelial Growth Factor C - genetics | Vascular Endothelial Growth Factor Receptor-3 - chemistry | Vascular Endothelial Growth Factor Receptor-2 - chemistry | Animals | Hydrogen Bonding | Vascular Endothelial Growth Factor C - metabolism | Protein Binding | Recombinant Fusion Proteins - genetics | Protein Conformation | Kinetics | Mutation | Vascular Endothelial Growth Factor Receptor-3 - genetics | Development and progression | Research | Growth factor receptors | Neovascularization | Properties | Vascular endothelial growth factor | Protein binding | Lymphangioma | Biological Sciences
Journal Article
Journal Article
Journal Article
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2018, Volume 2018, Issue 10, p. CD007419
.... Antiangiogenic therapy with anti‐vascular endothelial growth factor (anti‐VEGF) can reduce oedema, improve vision and prevent further visual loss... 
Endocrine & metabolic | Receptors, Vascular Endothelial Growth Factor | Vascular Endothelial Growth Factor A | Macular oedema | Laser Coagulation | Visual Acuity | Retinal disease | Angiogenesis Inhibitors | Recombinant Fusion Proteins | Bevacizumab | Randomized Controlled Trials as Topic | Diabetic eye disease | Aptamers, Nucleotide | Ranibizumab | Quality of Life | Macular Edema | Diabetes | Eyes & vision | Network Meta‐Analysis | Triamcinolone | Medicine General & Introductory Medical Sciences | Diabetic Retinopathy | Retinal disease (including age‐related macular degeneration) | CLINICAL-TRIAL | RANIBIZUMAB PLUS PROMPT | RANDOMIZED CONTROLLED-TRIAL | Receptors, Vascular Endothelial Growth Factor [therapeutic use] | DEFERRED LASER | MEDICINE, GENERAL & INTERNAL | PEGAPTANIB SODIUM | Bevacizumab [adverse effects; therapeutic use] | Laser Coagulation [methods] | Aptamers, Nucleotide [adverse effects; therapeutic use] | Network Meta-Analysis | QUALITY-OF-LIFE | Macular Edema [drug therapy; etiology; surgery] | Vascular Endothelial Growth Factor A [antagonists & inhibitors] | Visual Acuity [drug effects; physiology] | COST-EFFECTIVENESS | Angiogenesis Inhibitors [adverse effects; therapeutic use] | LASER PHOTOCOAGULATION | Ranibizumab [adverse effects; therapeutic use] | Recombinant Fusion Proteins [adverse effects; therapeutic use] | INTRAVITREAL BEVACIZUMAB | Diabetic Retinopathy [complications] | Triamcinolone [adverse effects; therapeutic use] | VEGF TRAP-EYE | Bevacizumab - therapeutic use | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Recombinant Fusion Proteins - adverse effects | Bevacizumab - adverse effects | Humans | Recombinant Fusion Proteins - therapeutic use | Ranibizumab - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Diabetic Retinopathy - complications | Macular Edema - etiology | Ranibizumab - adverse effects | Visual Acuity - drug effects | Triamcinolone - adverse effects | Laser Coagulation - methods | Angiogenesis Inhibitors - therapeutic use | Angiogenesis Inhibitors - adverse effects | Triamcinolone - therapeutic use | Visual Acuity - physiology | Aptamers, Nucleotide - therapeutic use | Aptamers, Nucleotide - adverse effects | Macular Edema - surgery | Macular Edema - drug therapy
Journal Article
Journal Article
Angiogenesis (London), ISSN 1573-7209, 2012, Volume 15, Issue 2, pp. 171 - 185
...ORIGINAL PAPER Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab Nicholas... 
Biomedicine | Age-related macular degeneration | Cancer Research | Oncology | Affinity | Ophthalmology | VEGF receptor | Cardiology | Aflibercept | Placental growth factor | Biomedicine general | Cell Biology | ANGIOGENESIS | EFFICACY | MACULAR DEGENERATION | PHASE-II | ANTIBODY | FACTOR THERAPY | EYE | IN-VITRO | PEGAPTANIB | RETINAL DISEASES | PERIPHERAL VASCULAR DISEASE | Angiogenesis Inhibitors - immunology | Receptors, Vascular Endothelial Growth Factor | Vascular Endothelial Growth Factor B - antagonists & inhibitors | Recombinant Fusion Proteins - pharmacology | Endothelial Cells - metabolism | Humans | Angiogenesis Inhibitors - pharmacology | Vascular Endothelial Growth Factor B - immunology | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Vascular Endothelial Growth Factor A - immunology | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Vascular Endothelial Growth Factor Receptor-2 - immunology | Enzyme Activation - drug effects | Bevacizumab | Endothelial Cells - immunology | Vascular Endothelial Growth Factor B - metabolism | Antibodies, Monoclonal, Humanized - pharmacology | HEK293 Cells | Ranibizumab | Vascular Endothelial Growth Factor Receptor-1 - immunology | Antibodies, Monoclonal, Humanized - immunology | Original Paper
Journal Article